lercanidipine, calcium channel blocker of the third generation: new possibilities in the treatment of arterial hypertension

Clicks: 173
ID: 246918
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #78 of 98 articles by views in environmental technology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract

Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine are detailed.

Reference Key
ostroumova2015racionalnalercanidipine, Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;O. D. Ostroumova;M. L. Maksimov;I. I. Kopchenov
Journal environmental technology
Year 2015
DOI
10.1234/1819-6446-2013-1-79-85
URL
http://www.rpcardio.ru/jour/article/view/77
Keywords
pharmacologydiseases of the circulatory (cardiovascular) system антигипертензивная терапия

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.